Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jun;9(3):1428–1436. doi: 10.21037/tau-20-725

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

2020 Translational Andrology and Urology. All rights reserved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0.

PMC Copyright notice

Representative photomicrographs of hematoxylin-eosin and immunohistochemistry staining of the case. (A) Prostate needle biopsy. Microscopic appearance of the prostatic adenocarcinoma with Gleason score: 4+4=8 (ISUP Grade 4); (B) diffuse and strong nuclear immunoexpression of Androgen Receptor (AR) (3+, 95% positivity); (C) moderated to strong cytoplasmic immunoexpression of MUC1 (2+~3+, 30% positivity); lack of expression of AR-V7 (D) and BRCA1 (E). All images are shown as ×200 magnification.